Drug Profile
FKB 01MD
Alternative Names: FKB01MD; TGBA 01ADLatest Information Update: 15 Mar 2017
Price :
$50
*
At a glance
- Originator Unknown
- Developer Fabre-Kramer Pharmaceuticals
- Class Antidepressants
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 1D receptor modulators; Serotonin 5-HT2 receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Major depressive disorder
Most Recent Events
- 15 Mar 2017 TGBA01AD is available for licensing. http://www.fabrekramer.com
- 08 Jan 2016 Phase-II development for Major depressive disorder is ongoing in USA
- 16 Nov 2011 TGBA01AD is available for licensing. http://www.fabrekramer.com